Preview: Altimmune's Earnings
Portfolio Pulse from Benzinga Insights
Altimmune (NASDAQ:ALT) is set to release its quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.46. The company's past performance shows a pattern of beating EPS estimates but experiencing a drop in share price. Altimmune's shares are currently trading at $3.01, down 78.47% over the last 52-week period.
August 09, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Altimmune is expected to report an EPS of $-0.46. Despite typically beating EPS estimates, the company's share price has historically dropped post-announcement. The stock is down 78.47% over the last year.
Altimmune's historical performance shows a pattern of beating EPS estimates but experiencing a drop in share price post-announcement. Given the stock's negative returns over the past year, investors are likely bearish going into this earnings release.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100